CWA
IONS icon

Clarus Wealth Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Clarus Wealth Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,200
Closed -$141K – 348
2019
Q2 		$141K Hold
2,200
– – 0.1% 151
2019
Q1 		$179K Sell
2,200
-1,000
-31% -$64.5K 0.13% 115
2018
Q4 		$173K Sell
3,200
-400
-11% -$20.4K 0.27% 97
2018
Q3 		$186K Buy
3,600
+2,400
+200% +$113K 0.12% 139
2018
Q2 		$53K Buy
+1,200
New +$53.2K 0.04% 277

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clarus Wealth Advisors's IONS Position: Q3 2019 in Review

Clarus Wealth Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 2,200 shares — an estimated $141K sold.

Clarus Wealth Advisors first reported a position in IONS in Q2 2018 and held it in 5 quarters. The position peaked at $186K in Q3 2018. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • Clarus Wealth Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Clarus Wealth Advisors sold 2,200 Ionis Pharmaceuticals shares in Q3 2019, an estimated $141K.
  • Clarus Wealth Advisors first reported a position in Ionis Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Clarus Wealth Advisors's Ionis Pharmaceuticals position peaked at $186K in Q3 2018.
  • 369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Clarus Wealth Advisors's 13F filing for Q3 2019, filed 11 Oct 2019.